The CLARITY initiative has great up-to-date infectious diseases content.
For instance:
The CLARITY initiative has great up-to-date infectious diseases content.
For instance:
Enteric Gram negative – an Enterobacterales species – e.g. E. coli, Klebsiella species, Enterobacter species Continue reading
Chronic hepatitis B is a major public health burden in most LMICscontributing to unnecessary suffering from liver failure and liver cancer leading to loss of life. Treatment is highly effective, safe, and affordable. Simplified treatment algorithms along with access to cheaper diagnostics and antiviral therapy has provided a pathway for the expansion of treatment.
Professor Alice Lee, based at Concord Hospital, Sydney, Australia, is international authority on viral hepatitis and the implementation of effective treatment programs across LMICs. Her organisation’s website, hepatitisBfree has a wealth of extensive guidelines including the algorithm below that derives from WHO treatment and care guidelines and the Asian consensus recommendations.
She has recently published this review which is important reading : Hepatitis D Review: Challenges for the Resource-Poor Setting . Hepatitis Delta is also an incredibly important issue for you to address / understand in your setting as its incidence will influence the impact of Hepatitis B treatment approaches. Here are the take home messages from Prof. Lee et al.:
After quite some planning and with the support of WHO and Burnet Institute, last week saw the convening of a Guideline Writing Committee in Port Moresby. The committee membership includes many senior PNG clinicians, co-chaired by Dr Goa Tau (NDOH) and Professor Robert Moulds (Therapeutic Guidelines, Australia. It was a great 2 day meeting with fantastic engagement. The various topic subgroups have now been set their homework and we meet again in November.
The guidelines will have primacy over antibiotic regimens in existing standard treatment guidelines that are pending updates. Alignment with the recently updated Paediatric Guidelines will be sought before their release. The current work is based on two recent Pacific Nations antibiotic guidelines – Fiji (2019) and Timor-Leste (2022).
Guest posting: Ms Tessa Oakley, Senior Bacteriology Scientist with the Timor-Leste Fleming Fund Country Grant and PRIDA member.
This excellent lecture is from a March 2022 session during the PRIDA Scientific Officer Microbiology Diploma course.
A useful adjunct to this talk is the practical 20 minute video masterclass provided by Dr Ashhurst-Smith here.
Produced by Dr Henry Butt, Senior Hospital Scientist, Newcastle, Australia in 1998.
See also:
Yeast summary April 2021 Townell
Dimorphic fungi not included.
Guest posting from Josh Davis, Infectious Diseases Physician, John Hunter Hospital, Newcastle, NSW.
Thanks Josh! He has selected the Top ID papers of 2020 Davis based on: